AAD rocks San Diego with new science, uptick in attendance

Dermatologists from around the world convened for the 76th Annual Meeting and blanketed the San Diego Convention Center as well as downtown itself. Attendees lined up for cutting-edge science, prestigious researchers and speakers, and hot topics and pearls, often in standing-room-only sessions or overflow locations.

Annual Meeting stats
Final numbers are still being audited, but our 2018 San Diego meeting counts are:

  • More than 18,800 total attendees. This is an increase over the past four Annual Meetings (2014 to 2017).
  • More than 4,800 physician member, life, and honorary member attendees. This surpasses 2017 Orlando numbers of 4,615, as well as 2016 Washington, D.C. numbers of 4,778.
  • Close to 10,000 medical personnel attendees. This is higher than the 2017 meeting (9,859), as well as the 2016 meeting (9,850).
  • Nearly 4,000 international attendees. The top 10 countries were Brazil, Mexico, Canada, United Kingdom, Colombia, Argentina, Spain, Pakistan, India, and Saudi Arabia.
  • 400 exhibitors.
  • Thousands of pearls shared among members.

Attendance at the Annual Meeting has been on an uptick for three years running, reaching more than 18,800 this year. The reason for the growth? The meeting delivers more education, valuable practice information, and networking opportunities than any other meeting in the specialty.

For example, Sunday’s Plenary session (P151), the centerpiece of the meeting, delivered timely and compelling presentations from passionate speakers.

Alan D. Irvine, MD, DSC, decried the prevalence of AD — up to 30% of children and up to 10% of adults. Citing his research, he advocated breaking the cycle during the Marion B. Sulzberger, MD, Memorial Award and Lectureship.

Jennifer A. Doudna, PhD, shared the dramatic and potentially controversial changes taking place in genome editing when she presented the Lila and Murray Gruber Memorial Cancer Research Award and Lectureship.

Mary-Margaret Chren, MD, made a case for dermatologists taking the vital signs of skin as another step in improving patient care during the Clarence S. Livingood Memorial Award and Lectureship.

Jan T. Vilcek, MD, PhD, whose lab developed infliximab, the first TNF inhibitor approved for clinical use, described the long and winding road his research took him on for the Eugene J. Van Scott Award for Innovative Therapy of the Skin and Phillip Frost Leadership Lecture.

Guest speaker Abraham Verghese, MD, predicted a health care revolution that would make the Industrial Revolution look like a blip when he presented “The Pathology Within: Burnout, Wellness, and the Search for Meaning in a Professional Life.”

Incoming AAD President Suzanne Olbricht, MD, and outgoing president Henry W. Lim, MD, took the stage to look back on one administration and then forward to an upbeat agenda for AAD and dermatologists.

“I want to go to work every day and do the best job I can taking care of my patients,” Dr. Olbricht said. “The AAD is enabling us to put all our focus where we want it to be — where it needs to be — on our patients.”

For more information about the 2018 AAD Annual Meeting sessions, claiming CME credit, and handouts, visit the education page. Also, view photos from the Annual Meeting at the AAD Meeting News Image Gallery.

More great meetings ahead
Be sure to mark your calendar for the 2018 AAD Summer Meeting July 26-29, 2018, in Chicago, as well as next year’s Annual Meeting March 1-5, 2019, in Washington, D.C.


Return to index